CVE-2025-24030

Envoy Admin Interface Exposed through prometheus metrics endpoint

Description

Envoy Gateway is an open source project for managing Envoy Proxy as a standalone or Kubernetes-based application gateway. A user with access to the Kubernetes cluster can use a path traversal attack to execute Envoy Admin interface commands on proxies managed by any version of Envoy Gateway prior to 1.2.6. The admin interface can be used to terminate the Envoy process and extract the Envoy configuration (possibly containing confidential data). Version 1.2.6 fixes the issue. As a workaround, the `EnvoyProxy` API can be used to apply a bootstrap config patch that restricts access strictly to the prometheus stats endpoint. Find below an example of such a bootstrap patch.

Category

7.1
CVSS
Severity: High
CVSS 3.1 •
EPSS 0.11%
Affected: envoyproxy gateway
Published at:
Updated at:

References

Frequently Asked Questions

What is the severity of CVE-2025-24030?
CVE-2025-24030 has been scored as a high severity vulnerability.
How to fix CVE-2025-24030?
To fix CVE-2025-24030, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2025-24030 being actively exploited in the wild?
As for now, there are no information to confirm that CVE-2025-24030 is being actively exploited. According to its EPSS score, there is a ~0% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
What software or system is affected by CVE-2025-24030?
CVE-2025-24030 affects envoyproxy gateway.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.